Location: Montreal, Quebec, Canada
CIK: 0001274413 · Show all filings
Period: Q4 2014 (← Previous) (Next →)
Filing Date: Feb 13, 2015
Total Value: $2.229B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BIIB | BIOGEN IDEC INC | 439,428 | $149M | 6.7% | $238.01 | +35.9% | COMMON | 09062X103 |
| AMGN | AMGEN INC | 894,473 | $142M | 6.4% | $75.69 | +49.7% | COMMON | 031162100 |
| — | CELGENE CORP | 1,134,258 | $127M | 5.7% | $99.53 | — | COMMON | 151020104 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 1,253,243 | $113M | 5.1% | $64.27 | +29.4% | COMMON | 09061G101 |
| INCY | INCYTE CORPORATION | 1,332,814 | $97.44M | 4.4% | $31.28 | +108.9% | COMMON | 45337C102 |
| — | MYLAN INC | 1,519,368 | $85.65M | 3.8% | $37.65 | — | COMMON | 628530107 |
| TEVA | TEVA PHARMACEUTICAL | 1,380,888 | $79.42M | 3.6% | $48.10 | — | ADR | 881624209 |
| REGN | REGENERON PHARMCEUTICALS | 185,685 | $76.18M | 3.4% | $257.11 | +52.1% | COMMON | 75886F107 |
| — | ALEXION PHARMACEUTICALS INC | 385,624 | $71.35M | 3.2% | $97.89 | — | COMMON | 015351109 |
| — | ACTAVIS PLC | 256,850 | $66.12M | 3.0% | $176.97 | — | SHARES | G0083B108 |
| TMO | THERMO FISHER SCIENTIFIC | 520,686 | $65.24M | 2.9% | $96.55 | +21.7% | COMMON | 883556102 |
| GILD | GILEAD SCIENCES INC | 684,307 | $64.5M | 2.9% | $37.24 | +92.9% | COMMON | 375558103 |
| PTCT | PTC THERAPEUTICS I | 1,135,130 | $58.77M | 2.6% | $24.35 | +80.8% | COMMON | 69366J200 |
| — | NPS PHARMACEUTICALS | 1,623,073 | $58.06M | 2.6% | $17.82 | — | COMMON | 62936P103 |
| — | SHIRE PLC | 236,124 | $50.19M | 2.3% | $178.67 | — | SP ADR | 82481R106 |
| — | KERYX BIOPHARMACEUTICALS | 3,257,358 | $46.09M | 2.1% | $13.93 | — | COMMON | 492515101 |
| — | MALLINCKRODT PLC | 400,664 | $39.68M | 1.8% | $57.67 | — | SHARES | G5785G107 |
| FOLD | AMICUS THERAPEUTICS | 4,765,498 | $39.65M | 1.8% | $6.80 | +1.0% | COMMON | 03152W109 |
| PRGO | PERRIGO CO | 232,068 | $38.79M | 1.7% | $142.01 | +10.1% | SHARES | G97822103 |
| RDY | DR REDDYS LABS LTD | 762,969 | $38.49M | 1.7% | $43.18 | — | ADR | 256135203 |
| PFE | PFIZER INC | 1,209,914 | $37.69M | 1.7% | $17.61 | +2.0% | COMMON | 717081103 |
| HALO | HALOZYME THERAPEUTICS | 3,724,351 | $35.94M | 1.6% | $8.25 | +7.7% | COMMON | 40637H109 |
| — | MEDIVATION INC | 356,806 | $35.54M | 1.6% | $98.29 | — | COMMON | 58501N101 |
| — | SEATTLE GENETICS INC | 1,104,075 | $35.47M | 1.6% | $33.06 | — | COMMON | 812578102 |
| — | ONCOMED PHARMACEUTICALS | 1,598,293 | $34.78M | 1.6% | $18.89 | — | COMMON | 68234X102 |
| — | ALLERGAN INC | 162,750 | $34.6M | 1.6% | $116.53 | — | COMMON | 018490102 |
| — | SYNAGEVA BIOPHARMA | 363,884 | $33.77M | 1.5% | $68.06 | — | COMMON | 87159A103 |
| — | PORTOLA PHARMACEUTICALS | 1,120,379 | $31.73M | 1.4% | $25.32 | — | COMMON | 737010108 |
| — | ACHILLION PHARMACEUTICALS | 2,373,810 | $29.08M | 1.3% | $12.25 | — | COMMON | 00448Q201 |
| — | INTERCEPT PHARMACEUTICALS | 181,847 | $28.37M | 1.3% | $228.44 | — | COMMON | 45845P108 |
| — | ACCELERON PHARMA | 713,995 | $27.82M | 1.2% | $33.26 | — | COMMON | 00434H108 |
| VRTX | VERTEX PHARMACEUTICALS | 212,250 | $25.21M | 1.1% | $73.84 | +52.5% | COMMON | 92532F100 |
| — | RELYPSA INC | 811,330 | $24.99M | 1.1% | $24.80 | — | COMMON | 759531106 |
| — | CLOVIS ONCOLOGY | 423,452 | $23.71M | 1.1% | $56.00 | — | COMMON | 189464100 |
| — | MEDTRONIC INC | 310,025 | $22.38M | 1.0% | $72.20 | — | COMMON | 585055106 |
| UTHR | UNITED THERAPEUTICS | 162,880 | $21.09M | 0.9% | $92.88 | +38.7% | COMMON | 91307C102 |
| — | SAGENT PHARMACEUTICALS | 833,861 | $20.94M | 0.9% | $22.38 | — | COMMON | 786692103 |
| — | KARYOPHARM THERAPEUTICS | 529,920 | $19.84M | 0.9% | $41.02 | — | COMMON | 48576U106 |
| ABT | ABBOTT LABS | 405,410 | $18.25M | 0.8% | $35.31 | 0.0% | COMMON | 002824100 |
| ISRG | INTUITIVE SURGICAL INC | 34,416 | $18.2M | 0.8% | $42.42 | +31.3% | COMMON | 46120E602 |
| — | MOMENTA PHARMACEUTICALS | 1,459,603 | $17.57M | 0.8% | $13.18 | — | COMMON | 60877T100 |
| ALGN | ALIGN TECH INC | 309,031 | $17.28M | 0.8% | $41.93 | +26.1% | COMMON | 016255101 |
| DXCM | DEXCOM INC | 286,065 | $15.75M | 0.7% | $8.00 | +53.0% | COMMON | 252131107 |
| — | AKORN INC | 434,343 | $15.72M | 0.7% | $15.40 | — | COMMON | 009728106 |
| — | NXSTAGE MEDICAL | 807,012 | $14.47M | 0.6% | $13.78 | — | COMMON | 67072V103 |
| — | HEARTWARE INTL INC | 168,525 | $12.38M | 0.6% | $88.35 | — | COMMON | 422368100 |
| HCA | HCA HLDGS INC | 144,002 | $10.57M | 0.5% | $65.33 | 0.0% | COMMON | 40412C101 |
| NVO | NOVO-NORDISK AS | 185,285 | $7.841M | 0.4% | $56.68 | — | ADR | 670100205 |
| AMPH | AMPHASTAR PHARMACEUTICALS | 660,232 | $7.665M | 0.3% | $10.42 | +4.5% | SHARES | 03209R103 |
| — | CYMABAY THERAPEUTICS | 708,585 | $6.965M | 0.3% | $6.84 | — | COMMON | 23257D103 |
| UHS | UNIVERSAL HEALTH SVC | 61,666 | $6.861M | 0.3% | $100.30 | 0.0% | CLASS B | 913903100 |
| INGN | INOGEN INC | 206,734 | $6.485M | 0.3% | $17.78 | +36.3% | COMMON | 45780L104 |
| NVS | NOVARTIS AG | 63,500 | $5.884M | 0.3% | $86.61 | — | SP ADR | 66987V109 |
| — | ALDER BIOPHARMACEUTICALS | 104,300 | $3.034M | 0.1% | $17.91 | — | COMMON | 014339105 |
| — | PROSENSA HLDGS | 111,432 | $2.089M | 0.1% | $12.88 | — | SHS USD | N71546100 |
| — | ZS PHARMA INC | 47,895 | $1.991M | 0.1% | $41.57 | — | COMMON | 98979G105 |
| ARAY | ACCURAY INC | 226,300 | $1.709M | 0.1% | $7.05 | 0.0% | COMMON | 004397105 |
| — | ADVAXIS INC | 210,850 | $1.689M | 0.1% | $8.01 | — | COMMON | 007624208 |
| — | TANDEM DIABETES CARE | 131,422 | $1.669M | 0.1% | $16.34 | — | COMMON | 875372104 |
| QURE | UNIQURE N.V. | 94,101 | $1.394M | 0.1% | $12.24 | 0.0% | SHARES | N90064101 |
| — | WUXI PHARMATECH ADS | 40,373 | $1.359M | 0.1% | $34.48 | — | SP ADR | 929352102 |
| — | ELEVEN BIOTHERAPEUTICS | 112,485 | $1.336M | 0.1% | $11.14 | — | COMMON | 286221106 |
| — | IMMUNE DESIGN CORP | 21,181 | $652K | 0.0% | $17.66 | — | COMMON | 45252L103 |
| — | VALEANT PHARMACEUTICALS INTL | 1,800 | $258K | 0.0% | $130.48 | — | COMMON | 91911K102 |